Inhibitors of sex steroid biosynthesis and methods for their pro

Details Inhibitors of sex steroid biosynthesis and methods for their pro Inhibitors of sex steroid biosynthesis and methods for their pro

1994-08-01

1996-12-17

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514717, 514719, 514731, 514964, A61K 31075, A61K 3105

Patent

active

055854052

ABSTRACT:
Certain steroidal and non-steroidal compounds have been found to inhibit androgen and estrogen formation. Such inhibition may aid in the reduction of the activity of these hormones and may be useful in the treatment of diseases where, for example, inhibition of androgen or estrogen activity is desired. Preferred inhibitors also possess antiestrogenic activity, thus providing the advantage of a double inhibitory action both on estrogen formation and on estrogen action (blockade of estrogen receptors by antiestrogenic action).

REFERENCES:
patent: 2875199 (1959-02-01), Cella et al.
patent: 3562260 (1971-02-01), DeRuggieri et al.
patent: 3975413 (1976-08-01), Pierdet et al.
patent: 3995060 (1976-11-01), Neri et al.
patent: 4055641 (1977-10-01), Benson et al.
patent: 4094994 (1978-06-01), Schonenberger
patent: 4096253 (1978-06-01), Wachter et al.
patent: 4139638 (1979-02-01), Neri et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4191759 (1980-03-01), Johnston et al.
patent: 4235893 (1980-11-01), Brodie et al.
patent: 4307111 (1981-12-01), Crawley
patent: 4386080 (1983-05-01), Crossley et al.
patent: 4472382 (1984-09-01), Labrie
patent: 4536516 (1985-08-01), Harper et al.
patent: 4547493 (1985-10-01), Teutsch et al.
patent: 4623660 (1986-11-01), Richardson
patent: 4634696 (1987-01-01), Teutsch et al.
patent: 4636505 (1987-01-01), Tucker et al.
patent: 4659516 (1987-04-01), Bowler et al.
patent: 4659695 (1987-04-01), Labrie
patent: 4732912 (1988-03-01), Pilgrim et al.
patent: 4751240 (1988-06-01), Bowler et al.
patent: 4760053 (1988-07-01), Labrie
patent: 4760061 (1988-07-01), Edwards et al.
patent: 4822528 (1989-04-01), Colombo et al.
patent: 4833135 (1989-05-01), Edwards et al.
patent: 4874754 (1989-10-01), Nique et al.
patent: 4904661 (1990-02-01), Pilgrim et al.
patent: 4943566 (1990-07-01), Nedelec et al.
patent: 5021414 (1991-06-01), Piligrim et al.
patent: 5023234 (1991-06-01), Labrie
patent: 5064813 (1991-11-01), Labrie
patent: 5204337 (1993-04-01), Labrie et al.
patent: 5364847 (1994-11-01), Labrie et al.
patent: 5372996 (1994-12-01), Labrie
patent: 5393785 (1995-02-01), Labrie et al.
patent: 5395842 (1995-03-01), Labrie et al.
New Zealand Patent Office Journal No. 1266 Abstract No. 201536, 1984.
New Zealand Patent Office Journal No. 1293 Jan. 1987, #206745.
New Zealand Patent Office Journal No. 1321 vol. 78; #214652, 1989.
New Zealand Patent Office Journal No. 1342 vol. 80 #222883, 1991.
Auchus et al., (1988) J. Biol. Chem., 263: 11640-11645.
Auchus et al., (1989) Steroids 53: 77-96.
Auchus et al., Biochem., (1986) 25:7295-7300.
Bhatnagar et al., (1978) J. Biol. Chem. 253: 811-815, 1978.
Blickenstaff et al., 46: (4 and 5) pp. 889-901 (1985).
Bucourt et al., J. Biol. Chem. 253: 8221, 1978.
Bull et al., J. Chem. Soc. Chem. Comm. pp. 451-453 (1986).
Chang et al., Biochemistry 21: (17) pp. 4103-4109 (1982).
Chin et al., J. Biol. Chem. 250: 7682-7686 (1975).
Chin et al., J. Biol. Chem. 255: 3660-3664 (1980).
Cooke, Jr., Tetrahedron Letters No. 22, pp. 1983-1986 (1973).
De Larminat, et al., "The Prostate" vol. 5, 1984, pp. 123-140.
Doorenbos et al., J. Pharm Sciences 63, 4, pp. 620-622 (1974).
Doorenbos et al., J. Pharm. Sciences 60:88, 1971, pp. 1234-1235.
Doorenbos et al. J. Pharm. Sciences 62, 4, pp. 638-640 (1973).
Farnsworth, Invest. Urology 6:(4) pp. 423-427 (1969).
Furr et al., J. Endo. 113, No. 3, vol. 113, Jun. 1987, pp. R7-R9.
Gibson et al., Angew Chem. Intl. Edit. vol. 7 (12) pp. 919-930 (1968).
Gohring et al., World Patent Information vol. 11, No. 1, 1989; pp. 5-10.
Green et al., Nature, 320: pp. 134-139, Mar. 1986.
Grunwell et al., Steroids 27:(6) pp. 759-771 (1976).
Gyorki et al., J. Steroid Biochem 25: (3) pp. 355-358 (1986).
Habenicht et al., The Prostate 11:313-326 (1987).
Important Advance in Oncology, pp. 193-217 (1985).
Jordon et al, Endocrinology 124, No. 4, (1989).
Klijin et al. J. Steroid Biochem. 20 (6B) (1984) p. 1381.
Labrie et al., Genitourinary Cancer ISBN 0-89838-830-9, 1987, pp. 157-200.
Labrie et al., J. Steroid Biochem 19: No. 1 pp. 999-1007 (1984).
Labrie et al., Satellite Symposium, 7th Intl. Congress of Endocrino, abstract form (1988).
Labrie et al. The Prostate 4:579-594 (1983).
Lee et al., J. Androl. 1981; 2:293-299.
Lefebvre et al., 2-Mammalian Hormones, vol. 99, No. 99:188132r (1985).
Levesque et al. J. Med Chem, 34, pp. 1624-30, 1991.
Levy et al. Biochemistry. 26:2270-2279 (1987).
Lubahn et al., Science 240:327-330 (1988).
Lubahn et al., Proc Natl Acad. Sci. 86:9534-9538 (1989).
Luthy et al., J. Steroid Biochem. 31: (5) pp. 845-882 (1988).
Macaulay et al., J. Steroid Biochem. 26: (5) 535-588 (1988).
McDonald et al., J. Pharm and Exper. Therapeutics 244: pp. 428-431 (1987).
Mobbs et al., No. 1410 abstract (1989).
Murdock et al. Biochem. 27: 4432-4438, (1988).
Musto et al. Endocrine Research Comm; vol. 4, No. 2, 1977, pp. 147-157.
Nayfeh et al., Steroids 14:3 pp. 269-283 (1969).
Neri et al., J. Stero. Biochem., 6: pp. 815-819 (1975).
Neumann et al., Clinics in Oncology 1: (1) pp. 41-64 (1982).
Pittaway D. E. Contraception 27:431-436, (1983).
Plante et al., J. Steroid Biochem, vol. 13; (1) pp. 61-64 (1988).
Poulin et al., Cancer Res. 46:4933-4937, (1986).
Raucher et al. J. Org. Chem 1981, 46, 3558-3559.
Redding et al., Proc. Natl. Acad. Sci. USA vol. 80 pp. 1459-1462 (1983).
Salman et al., J. Steroid Biochem, 33, No. 1, pp. 25-31, 1989.
Schally et al., Cancer Treatment Reports vol. 68 (1) pp. 281-288 (1984).
Schwarz et al., Organic Synthesis Collective Vol. 3: 332-333 (1990).
Seguin et al., Mol. Cell. Endocrinol. 21: pp. 37-41 (1981).
Simard et al. Mol. Cell. Endocrinology 44: pp. 775-783 1988.
Solo, et al., Steroids vol. 40, No. 6, Dec. 1982, pp 603-614.
Strickler et al., J. Biol. Chem. 256:316-321, (1981).
Thomas et al., J. Biol. Chem. 258: 11500-11504 (1983).
Thomas et al., J. Biol. Chem. 248: 1587-1590 (1983).
Thomas et al., J. Steroid Biochem. 25: 103-108 (1986).
Tobias et al., J. Biol. Chem. 257:2783-2786 (1982).
Tora et al. EMBO 8 (7) pp. 1981-1986 (1989).
Voigt et al., Endo 92 (4) pp. 1216-1222, (1973).
Wagner et al., 21 Symposium Dstch. Ges. Endodrin. Abstract 52 (1975).
Wakeling, et al. J. Endocr., 112, R7-R10, 1987.
Wakeling & Bowler, J. Steroid Biochem 30: 141-147, 1988.
Wang et al., Can J. Chem. 65:2727-2831 (1987).
Warren et al., Am. J. Obstet. Gynecol. 129: 789-794 (1977).
Weiss et al., Angew. Chem. Int'l Edit. 12(10):841 (1973).
Dobernauer, et al, "Advanced Male Breast Cancer . . . ", Cancer 62: 474-478, (1988).
Fevig et al., Steroids 51 (1988) pp. 471-497.
Heiman et al., J. Med. Chem., 23(1980) pp. 994-1002.
Klingmuller et al., p. 1395 No. A62 abstract (1988).
Landvatter et al., J. Med. Chem. pp. 1300-1307, (1982).
Mouridsen et al., Cancer Treatment Review 5: pp. 131-141 (1978).
Santen et al., p. 1375 No. A22 Abstract (1988).
Von Angerer, et al., J. Med. Chemistry, 1984 27, 1439-1447.
Weatherill et al., J. Steroid Biochem. 30: No 1-6 pp. 263-266 (1988).

Affiliated with

Also associated with

Rating

Inhibitors of sex steroid biosynthesis and methods for their pro does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of sex steroid biosynthesis and methods for their pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of sex steroid biosynthesis and methods for their pro will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1991641